mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.6 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |